With the stock currently trading at Rs 1,245, Dr Reddys Laboratories demonstrates a positive movement in today's session.

Dr Reddys Laboratories Ltd is quoting at Rs 1249.8, up 2.42% on the day as on 12:44 IST on the NSE. The stock is down 8.12% in last one year as compared to a 1.97% spurt in NIFTY and a 0.6% spurt in ...

Welcome to the Dr Reddys Stock Liveblog, your real-time source for the latest updates and comprehensive analysis on a ...

Dr. Reddy's Laboratories Ltd. closed 14.15% below its 52-week high of 1,420.20 rupees, which the company reached on August ...

Hyderabad: Dr Reddy's Labs has announced that the Company has received the Establishment Inspection Report (EIR) from the ...

Dr Reddys Laboratories Ltd is up for a third straight session in a row. The stock is quoting at Rs 1224.4, up 1.07% on the ...

Discover the Dr Reddys Stock Liveblog, your ultimate resource for real-time updates and insightful analysis on a prominent ...

Among Indian generics makers, Iron Sucrose had been considered a key pipeline product for Dr. Reddy’s Laboratories and ...

With the stock's last traded price at Rs 1,200.30, Dr Reddys Labs was among the top losers on Nifty 50 at 10:00 am.

Dr Reddy's Laboratories plans to launch a cheaper copycat version of Novo Nordisk's blockbuster weight-loss drug Wegovy in 87 countries next year, the Indian drugmaker's CEO, Erez Israeli, said on ...

The USFDA has classified the inspection outcome as "Voluntary Action Indicated" (VAI) and confirmed that the inspection is officially closed.

Dr. Reddy's Laboratories Ltd. closed 14.12% below its 52-week high of 1,420.20 rupees, which the company reached on August ...